Cargando…
Anti-Carbonic Anhydrase II Antibodies in End-Stage Renal Disease Patients
OBJECTIVE: The aim of this study was to investigate the presence of anti-carbonic anhydrase (CA II) autoantibodies in patients with end-stage renal disease (ESRD) and relationships between the autoantibody titers and ghrelin, glucose, blood urea nitrogen (BUN) and creatinine. SUBJECTS AND METHODS: S...
Autores principales: | Alver, Ahmet, Menteşe, Ahmet, Menteşe, Ümit, Sümer, Ayşegül, Uçar, Fahri, Us Altay, Diler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586897/ https://www.ncbi.nlm.nih.gov/pubmed/24903210 http://dx.doi.org/10.1159/000362667 |
Ejemplares similares
-
Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
por: Menteşe, Ahmet, et al.
Publicado: (2017) -
Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia
por: Mentese, Ahmet, et al.
Publicado: (2018) -
Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer
por: Mentese, Ahmet, et al.
Publicado: (2017) -
The diagnostic value of FNDC5/Irisin in renal Cell Cancer
por: Altay, Diler Us, et al.
Publicado: (2018) -
The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients
por: Türk, Adem, et al.
Publicado: (2017)